Hemoglobin Feed Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Bovine, Swine, Poultry, Shark, Synthetic, Others), By Application (Industrial, Commercial), Region and Competition, 2019-2029F

Published Date: February - 2025 | Publisher: MIR | No of Pages: 320 | Industry: Agriculture | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Hemoglobin Feed Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Bovine, Swine, Poultry, Shark, Synthetic, Others), By Application (Industrial, Commercial), Region and Competition, 2019-2029F

Forecast Period 2025-2029
Market Size (2023) USD 225.21 million
Market Size (2029) USD 284.61 million
CAGR (2024-2029) 4.15%
Fastest Growing Segment Swine
Largest Market North America

Market Overview

Global Hemoglobin Feed Market was valued at USD 225.21 million in 2023 and is anticipated to grow with a CAGR of 4.15% through 2029.

The global hemoglobin feed market is a vital component of the animal nutrition industry, catering primarily to livestock and aquaculture sectors. Hemoglobin feed, derived from animal blood, serves as a rich source of essential nutrients, including proteins, amino acids, iron, and vitamins, making it a valuable dietary supplement for livestock and aquatic species.

 Download Sample  Ask for Discount  Request Customization 

Global Hemoglobin Feed Market has witnessed significant growth due to the rising demand for high-quality animal protein products, coupled with increasing awareness about the importance of balanced nutrition in animal husbandry practices. Key factors driving the growth of the global hemoglobin feed market include the expanding global population, growing consumer preference for protein-rich diets, and the rising demand for animal-based products such as meat, eggs, and dairy. The shift towards sustainable and environmentally friendly farming practices has spurred interest in alternative protein sources like hemoglobin feed, which can contribute to improved animal health and productivity while reducing environmental impact.

The advancements in processing technologies have led to the development of innovative hemoglobin feed products with enhanced nutritional profiles and improved digestibility, further fueling market growth. As the demand for high-quality animal protein continues to rise, the global hemoglobin feed market is expected to witness continued expansion, providing lucrative opportunities for manufacturers, suppliers, and stakeholders in the animal nutrition sector. Hemoglobin feed is a nutrient-rich supplement derived from animal blood, notably cattle or swine. It serves as a valuable source of proteins, amino acids, iron, and vitamins for livestock and aquaculture. Hemoglobin feed enhances animal health, growth, and productivity while ensuring balanced nutrition. With its high nutritional value, it contributes to the production of quality animal protein products such as meat, eggs, and dairy. Hemoglobin feed supports sustainable farming practices by offering an environmentally friendly alternative protein source. Its usage aligns with the growing demand for nutritious animal feed and underscores its significance in modern agriculture and aquaculture industries.

Key Market Drivers

Increasing Demand for Animal Protein

Global Hemoglobin Feed Market is witnessing a significant surge in demand, primarily driven by the escalating global appetite for animal protein. As the world's population continues to expand, particularly in emerging economies, there is a corresponding rise in the consumption of meat, eggs, dairy, and other animal-derived products. Hemoglobin feed emerges as a crucial component in addressing this demand, offering a nutrient-rich supplement derived from animal blood. Packed with essential nutrients such as proteins, amino acids, iron, and vitamins, hemoglobin feed plays a vital role in enhancing the health, growth, and productivity of livestock and aquatic species. Its nutritional profile aligns perfectly with the requirements for optimal animal nutrition, making it an indispensable component of modern animal feed formulations. The rising awareness of the importance of balanced animal nutrition among farmers and livestock producers further underscores the significance of hemoglobin feed in meeting the increasing demand for animal protein. By providing a concentrated source of essential nutrients, hemoglobin feed helps ensure that animals receive the necessary dietary requirements for healthy growth and development.

The increasing demand for animal protein is a key driver propelling the growth of the Global Hemoglobin Feed Market. As the need for protein-rich diets continues to rise, hemoglobin feed stands poised to play a pivotal role in supporting sustainable and efficient animal production systems worldwide.

Nutritional Benefits


MIR Segment1

 Download Sample  Ask for Discount  Request Customization 


Sustainable Farming Practices

Sustainable farming practices are increasingly becoming a focal point in agriculture, driving the Global Hemoglobin Feed Market towards a more environmentally conscious approach. Hemoglobin feed, derived from animal blood, aligns with the principles of sustainability by offering an environmentally friendly alternative protein source for livestock and aquaculture industries. As concerns about environmental degradation and resource depletion intensify, there is a growing demand for sustainable solutions that minimize the ecological footprint of agricultural activities. Hemoglobin feed contributes to sustainable farming practices in several ways. It utilizes co-products from the meat processing industry, thereby reducing waste and promoting resource efficiency. By repurposing animal blood, hemoglobin feed helps mitigate environmental pollution and landfill burden associated with organic waste disposal. Hemoglobin feed offers a nutrient-dense supplement that enhances animal health and productivity, reducing the need for excessive feed inputs and antibiotics. Healthy animals require fewer medical interventions and are more efficient in converting feed into meat, milk, or eggs. This, in turn, promotes resource efficiency and reduces the environmental impact of animal production systems. The hemoglobin feed supports sustainable intensification of livestock and aquaculture operations by optimizing nutrient utilization and minimizing nutrient losses to the environment. By providing essential nutrients in a concentrated form, hemoglobin feed enables farmers to achieve higher productivity levels with fewer inputs, thus reducing the ecological footprint per unit of output. The adoption of hemoglobin feed in animal nutrition programs represents a step towards more sustainable farming practices. As the demand for environmentally friendly agricultural solutions continues to grow, hemoglobin feed stands poised to play a pivotal role in driving sustainability across the Global Hemoglobin Feed Market.

Key Market Challenges

Regulatory Compliance

Regulatory compliance is a critical aspect of the Global Hemoglobin Feed Market, governing the production, distribution, and use of hemoglobin feed in animal nutrition. Due to its origin from animal blood, hemoglobin feed is subject to stringent regulations and oversight by regulatory authorities in different countries and regions. Compliance with these regulations is essential to ensure product safety, efficacy, and legal market access. One of the primary challenges in regulatory compliance for the hemoglobin feed market is the variability in regulatory requirements across different jurisdictions. Each country or region may have its own set of regulations governing the use of animal-derived ingredients in animal feed, as well as specific requirements for labeling, safety, and quality standards. Navigating this complex regulatory landscape requires a thorough understanding of local regulations and the ability to adapt to changing compliance requirements. The regulatory compliance often involves extensive documentation, testing, and certification processes, adding to the administrative burden and operational costs for manufacturers and suppliers of hemoglobin feed. Compliance with Good Manufacturing Practices (GMP), Hazard Analysis and Critical Control Points (HACCP), and other quality assurance standards is essential to ensure product safety and consistency. The regulatory compliance extends beyond national boundaries, particularly in the context of international trade. Exporting hemoglobin feed products to foreign markets requires adherence to import regulations, customs clearance procedures, and compliance with international trade agreements and standards.

Supply Chain Management


MIR Regional

 Download Sample  Ask for Discount  Request Customization 


Key Market Trends

Rising Demand for Animal Protein

Segmental Insights

Source Insights

Based on

Application Insights

Based on application, commercial segment dominated the Global Hemoglobin Feed Market in 2023. This can be ascribed to the widespread adoption of hemoglobin feed in commercial livestock and aquaculture operations. Commercial enterprises prioritize efficient and cost-effective animal nutrition solutions to maximize production outcomes. Hemoglobin feed, with its high nutritional value and beneficial effects on animal health and growth, aligns with these objectives. Moreover, commercial producers often have larger-scale operations and greater purchasing power, enabling them to procure hemoglobin feed in bulk quantities. This, coupled with the increasing demand for animal protein, drives the dominance of the commercial segment in the Global Hemoglobin Feed Market.

Regional Insights

Asia Pacific region emerged as the fastest growing region in the global hemoglobin feed market, with China leading the way. The remarkable growth witnessed in this region can be attributed to the extensive production of plasma and hemoglobin powder within China. China plays a pivotal role as both a major producer and consumer of pig blood by-products, including plasma and hemoglobin feed. This growth is fueled by a surge in meat and seafood consumption, driven by factors such as increasing disposable income, urbanization, and population growth. The abundance of porcine blood generated in Chinese butcher shops contributes to the rising volume of hemoglobin powder.

Recent Developments

  • In October 2023, Genexine and KGbio celebrated a significant achievement with the approval of their long-acting erythropoietin, Efepoetin alfa (GX-E4), by the Indonesian Ministry of Food and Drug Safety (BPOM). This approval was specifically for the treatment of chronic kidney disease-induced anemia in non-dialysis patients. The collaboration between Genexine and KGbio bore fruit with this milestone, marking the first market approval for a drug resulting from their joint research and development efforts. This development was not only a testament to their dedication to advancing medical treatment but also held promise for improving the lives of individuals affected by chronic kidney disease-induced anemia.

Key Market Players

Table of Content

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Overview

1.2. Key Findings

1.3. Market Segmentation

1.4. Competitive Landscape

1.5. Challenges and Opportunities

1.6. Future Outlook

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the study

2.2.1. Research Objective

2.2.2. Assumption

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.2. Porter's Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. HEMOGLOBIN FEED MARKET, BY HEMOGLOBIN SOURCE (USD BILLION)

6.1. Bovine

6.2. Porcine

7. HEMOGLOBIN FEED MARKET, BY FEED TYPE (USD BILLION)

7.1. Hemoglobin Powder

7.2. Hemoglobin Concentrate

7.3. Hemoglobin Meal

8. HEMOGLOBIN FEED MARKET, BY LIVESTOCK (USD BILLION)

8.1. Poultry

8.2. Aquaculture

8.3. Swine

8.4. Ruminants

9. HEMOGLOBIN FEED MARKET, BY FORM (USD BILLION)

9.1. Dry

9.2. Liquid

9.3. Paste

10. HEMOGLOBIN FEED MARKET, BY FUNCTION (USD BILLION)

10.1. Iron Supplementation

10.2. Hematopoiesis Stimulation

11. HEMOGLOBIN FEED MARKET, BY REGIONAL (USD BILLION)

11.1. North America

11.1.1. US

11.1.2. Canada

11.2. Europe

11.2.1. Germany

11.2.2. UK

11.2.3. France

11.2.4. Russia

11.2.5. Italy

11.2.6. Spain

11.2.7. Rest of Europe

11.3. APAC

11.3.1. China

11.3.2. India

11.3.3. Japan

11.3.4. South Korea

11.3.5. Malaysia

11.3.6. Thailand

11.3.7. Indonesia

11.3.8. Rest of APAC

11.4. South America

11.4.1. Brazil

11.4.2. Mexico

11.4.3. Argentina

11.4.4. Rest of South America

11.5. MEA

11.5.1. GCC Countries

11.5.2. South Africa

11.5.3. Rest of MEA

12. COMPETITIVE LANDSCAPE

12.1. Overview

12.2. Competitive Analysis

12.3. Market share Analysis

12.4. Major Growth Strategy in the Hemoglobin Feed Market

12.5. Competitive Benchmarking

12.6. Leading Players in Terms of Number of Developments in the Hemoglobin Feed Market

12.7. Key developments and growth strategies

12.7.1. New Product Launch/Service Deployment

12.7.2. Merger & Acquisitions

12.7.3. Joint Ventures

12.8. Major Players Financial Matrix

12.8.1. Sales and Operating Income

12.8.2. Major Players R&D Expenditure. 2023

13. COMPANY PROFILES

13.1. Talecris Biotherapeutics, Inc.

13.1.1. Financial Overview

13.1.2. Products Offered

13.1.3. Key Developments

13.1.4. SWOT Analysis

13.1.5. Key Strategies

13.2. Octapharma AG

13.2.1. Financial Overview

13.2.2. Products Offered

13.2.3. Key Developments

13.2.4. SWOT Analysis

13.2.5. Key Strategies

13.3. CSL Behring AG

13.3.1. Financial Overview

13.3.2. Products Offered

13.3.3. Key Developments

13.3.4. SWOT Analysis

13.3.5. Key Strategies

13.4. Sangart, Inc.

13.4.1. Financial Overview

13.4.2. Products Offered

13.4.3. Key Developments

13.4.4. SWOT Analysis

13.4.5. Key Strategies

13.5. Biopure Corporation

13.5.1. Financial Overview

13.5.2. Products Offered

13.5.3. Key Developments

13.5.4. SWOT Analysis

13.5.5. Key Strategies

13.6. Kedrion S.p.A.

13.6.1. Financial Overview

13.6.2. Products Offered

13.6.3. Key Developments

13.6.4. SWOT Analysis

13.6.5. Key Strategies

13.7. Hemosol, Inc.

13.7.1. Financial Overview

13.7.2. Products Offered

13.7.3. Key Developments

13.7.4. SWOT Analysis

13.7.5. Key Strategies

13.8. Hemoglobin Oxygen Therapeutics, Inc.

13.8.1. Financial Overview

13.8.2. Products Offered

13.8.3. Key Developments

13.8.4. SWOT Analysis

13.8.5. Key Strategies

13.9. Fresenius Kabi AG

13.9.1. Financial Overview

13.9.2. Products Offered

13.9.3. Key Developments

13.9.4. SWOT Analysis

13.9.5. Key Strategies

13.10. Grifols, S.A.

13.10.1. Financial Overview

13.10.2. Products Offered

13.10.3. Key Developments

13.10.4. SWOT Analysis

13.10.5. Key Strategies

13.11. Samsung Bioepis Co., Ltd.

13.11.1. Financial Overview

13.11.2. Products Offered

13.11.3. Key Developments

13.11.4. SWOT Analysis

13.11.5. Key Strategies

13.12. Baxter Healthcare Corporation

13.12.1. Financial Overview

13.12.2. Products Offered

13.12.3. Key Developments

13.12.4. SWOT Analysis

13.12.5. Key Strategies

13.13. Shire Plc.

13.13.1. Financial Overview

13.13.2. Products Offered

13.13.3. Key Developments

13.13.4. SWOT Analysis

13.13.5. Key Strategies

13.14. Pfizer, Inc.

13.14.1. Financial Overview

13.14.2. Products Offered

13.14.3. Key Developments

13.14.4. SWOT Analysis

13.14.5. Key Strategies

14. APPENDIX

14.1. References

14.2. Related Reports

List Tables Figures

List of Tables and Figures

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.